Autonomix Medical (AMIX) Gains from Sales and Divestitures (2024 - 2025)
Autonomix Medical (AMIX) reported Gains from Sales and Divestitures of $1604.0 for Q1 2025, down 45.01% year-over-year from $2917.0 in Q1 2024, and up 22.26% quarter-over-quarter from $1312.0 in Q4 2024.
Autonomix Medical (AMIX) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Autonomix Medical (AMIX) has 2 years of Gains from Sales and Divestitures data on file, last reported at $1604.0 in Q1 2025.
- Gains from Sales and Divestitures for Q1 2025 came in at $1604.0, down 45.01% year-over-year; the trailing twelve-month figure through Mar 2025 was $1604.0 (down 45.01% YoY), and the FY2025 annual result was $1604.0, down 45.01% from the prior year.
- Gains from Sales and Divestitures advanced to $1604.0 in Q1 2025 per AMIX's latest filing, from $1312.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $8750.0 in Q2 2024 and troughed at $875.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Autonomix Medical | 3.33 Mn | 3.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,604.00 |
| Mar 31, 2025 | 1,604.00 |
| Dec 31, 2024 | 1,312.00 |
| Dec 31, 2024 | 1,312.00 |
| Sep 30, 2024 | 875.00 |
| Sep 30, 2024 | 875.00 |
| Jun 30, 2024 | 8,750.00 |
| Jun 30, 2024 | 8,750.00 |
| Mar 31, 2024 | 2,917.00 |
| Mar 31, 2024 | 2,917.00 |